Biotech Startups

EdenRoc Sciences is a life sciences holding company that founds and funds subsidiary biotechnology companies addressing diseases of aging, with assets spanning genomic detection, clinical-stage pharmaceuticals, forensics, and biologic-based consumer products. Its subsidiaries operate autonomously while sharing board oversight and centralized business functions, and its work spans diagnostics and therapeutics across biotech and healthcare markets.

1 investor

EDGC (Eone-Diagnomics Genome Center) is a Korean genomics healthcare company that provides genetic analysis services across life stages, including non-invasive prenatal testing (NIPT) branded "The Mom's Scanning" and liquid biopsy-based cancer diagnostics using cell-free DNA and next-generation sequencing. Listed on KOSDAQ, it offers its prenatal testing in around 40 countries and positions itself as an AI genomics company.

1 investor

Edgewood Oncology is a clinical-stage biotechnology company developing BTX-A51, a first-in-class treatment candidate for hematologic malignancies and genetically-defined solid tumors. The company focuses on addressing unmet medical needs in cancer treatment.

1 investor

Edian provides data-driven go/no-go intelligence to help drug development decision committees evaluate molecular programs and advance drug candidates. It serves research labs and pharmaceutical decision-makers in the biotech and drug discovery space.

1 investor

EditCo manufactures arrayed CRISPR guide RNA libraries for functional genomics screening, using its proprietary XDel technology to achieve high-efficiency gene knockouts in human and mouse cell lines. The company serves research institutions and biotech companies conducting target discovery and validation studies.

1 investor

EDX Medical is a healthcare/medical services company led by experienced directors from the pharmaceutical, biotech, and medical sectors. The company appears to operate in the medical diagnostics and laboratory services space based on its team's expertise in laboratory management, pathology, and life sciences.

1 investor

Effa, based in the United States, makes disposable personal care products intended as alternatives to conventional plastic items. Its toothbrush uses a handle made from recycled paper with a corn starch–based laminate coating and bristles from a nylon formulated to break down more quickly, and is sold to consumers looking for lower-waste options.

1 investor

Efor provides quality and compliance consulting and AI-enabled digital tools for Life Sciences companies, covering project management, CQV & CSV activities, quality management, process industrialization and operational excellence. It serves pharmaceutical and health product manufacturers, helping them meet cGMP regulatory requirements across the industrial value chain.

1 investor

Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products. It operates in the pharmaceutical industry focused on pain treatment.

1 investor

Egetis Therapeutics is a pharmaceutical company developing treatments for rare and serious diseases, including Emcitate (tiratricol) for MCT8 deficiency. Its work centers on orphan drug development in the biotech and healthcare space.

1 investor

1 investor

Eikonizo develops small molecule therapeutics targeting neurodegenerative and cardiorenal diseases. The company is focused on creating novel, disease-modifying treatments to improve patient outcomes.

1 investor

Eilean Therapeutics is a small molecule oncology drug discovery company developing pan-variant therapies that target resistance mechanisms in hematologic malignancies. Founded in 2022, it focuses on creating first- and best-in-class treatments for blood cancers that have developed resistance to existing therapies.

1 investor

Eisai is a global research-based pharmaceutical company focused on neurology and oncology, with a commitment to patient-centric healthcare solutions worldwide.

1 investor

EKF Diagnostics is a global diagnostics and biotechnology company that develops and manufactures point-of-care medical devices, laboratory tests, and life sciences reagents for healthcare professionals and research applications. The company operates manufacturing facilities in the US and Germany and distributes products across over 120 countries.

1 investor

Ekidna develops a lab-on-a-chip system for rapid, decentralized testing of cannabinoids, using electrochemical sensors to detect compounds in various sample types. It serves cannabis growers and product manufacturers.

1 investor

Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.

1 investor

Electro-Active Technologies, spun out of Oak Ridge National Laboratory, develops microbial electrolysis systems that convert organic waste streams such as food waste into hydrogen. The company applies bioelectrochemical technology to waste-to-hydrogen production.

1 investor

Eledon Pharmaceuticals is a clinical-stage biotechnology company developing immunology-based therapies, with a focus on protecting transplanted organs from rejection and treating autoimmune and neurodegenerative diseases including ALS. The company's lead candidate is tegoprubart, an anti-CD40L antibody.

1 investor

ELEM develops healthcare digital twins using biosimulation technology to enable pharmaceutical and medical device companies to test and predict treatment outcomes before clinical trials. The company combines biomedical science, mechanistic modeling, AI, and high-performance computing to replicate human physiology for safer, more efficient drug and device development.

1 investor

ElementZero Biolabs produces reagents that boost the amplification of DNA and RNA targets present at very low concentrations, reporting roughly 100 times greater sensitivity than standard approaches. The chemistry is intended for point-of-care and research settings, allowing genetic markers to be detected without specialized instruments or extended protocols.

1 investor

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue. The company serves oncologists and patients to enable personalized cancer treatment selection.

1 investor

Focused on serotonin 2A receptor agonists (psychedelics) by managing psychoactivity. (Exited)

1 investor

Elgan Pharma is a clinical-stage biopharmaceutical company developing therapies for premature infants and neonates, including treatments for intestinal maturation and retinopathy of prematurity.

1 investor